Blood–brain-barrier-crossing lipid nanoparticles (IMAGE)
Caption
Blood–brain-barrier-crossing lipid nanoparticles (BLNPs) effectively and safely deliver mRNA to the brain via systemic administration.
Credit
Created with BioRender.com in the lab of Yizhou Dong, PhD, at the Icahn School of Medicine at Mount Sinai.
Usage Restrictions
May be used only within the context of this news.
License
Original content